Skip to content
ESE logo
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

Authors

Martin Fassnacht, Olaf M Dekkers, Tobias Else, Eric Baudin, Alfredo Berruti, Ronald R de Krijger, Harm R Haak, Radu Mihai, Guillaume Assie, Massimo Terzolo

Developed By:

The European Society of Endocrinology, including representatives from the European Network for the Study of Adrenal Tumors, the Endocrine Society and the European Society of Endocrine Surgeons. 

Introduction

Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with best possible evidence-based recommendations for clinical management of patients with ACC based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system.
This guideline was developed for healthcare providers involved in the care of patients with ACC, i.e., endocrinologists, oncologists, surgeons, radiologists, nuclear medicine physicians, radio-oncologists, pathologists, specialists in general internal medicine and nurse specialists. However, general practitioners or gynecologists or dermatologists (who are involved in the diagnostic of androgen excess) might also find the guideline useful, as might our patients.

European Journal of Endocrinology, Volume 179, Issue 4, Oct 2018, Pages G1–G46

Read the full Guideline

Related Resources

A number of additional resources were also made available. 

Published
01/10/2018
Tags
Guidelines , ESE Guideline , Adrenal and Cardiovascular Endocrinology ,
Other Publications

To see all published guidelines, journals, reports and statements, view all publications